© 2024 Ideastream Public Media

1375 Euclid Avenue, Cleveland, Ohio 44115
(216) 916-6100 | (877) 399-3307

WKSU is a public media service licensed to Kent State University and operated by Ideastream Public Media.
Play Live Radio
Next Up:
0:00 0:00
Available On Air Stations
To contact us with news tips, story ideas or other related information, e-mail newsstaff@ideastream.org.

Vaccine To Prevent Certain Cancers Remains Underutilized

Dr. Douglas Lowy, acting director of the National Cancer Institute, discusses his role in helping to develop the HPV vaccine with Kay Colby on a recent visit to University Hospital's Seidman Cancer Center.

A vaccine to prevent a virus known to cause at least four kinds of cancer is one of the most underutilized vaccines on the market today, according to data from the Centers for Disease Control and Prevention. The vaccine is designed to protect against certain strains of a sexually transmitted infection called the human papillomavirus – or HPV. These strains cause almost all cases of cervical cancer, as well as four other kinds of cancer. Strains of the virus are also suspected to cause some forms of throat cancer, as well as penile cancer. Health producer Kay Colby sat down with Rick Jackson to talk about why HPV vaccination rates remain low and what's being done to address the issue. 

To view the CDC report on teen vaccination click here

To view a fact sheet on the HPV vaccine from the Kaiser Family Foundation click here

kay.colby@ideastream.org | 216-916-6410